No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RADCQ250117P3000
- 2.90
- 0.000.00%
15min DelayTrading Nov 15 14:43 ET
0.00High0.00Low
0.00Open2.90Pre Close0 Volume724 Open Interest3.00Strike Price0.00Turnover0.00%IV-400.00%PremiumJan 17, 2025Expiry Date2.98Intrinsic Value100Multiplier191DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.01Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
A U.S. bankruptcy judge has approved Rite Aid Corp's (OTC:RADCQ) restructuring plan, enabling the pharmacy chain to reduce its debt by $2 billion and transfer control to a group of lenders.Rite Aid fi
Rite Aid Bankruptcy Bid Approved by Court
Rite Aid Averts Total Closure, Wins Restructuring Plan Approval
Express News | Rite Aid Bankruptcy Plan Approved, Cutting $2 Bln in Debt - Judge
Why Walgreens, CVS and Rite Aid Are Closing Thousands of Drug Stores Across America
Rite Aid Closing 27 More Stores in 2 States: See the Locations
Comments
Rite Aid's CEO, Jeffrey S. Stein, believes the MedImpact transaction optimizes business value and prepares Elixir for future client support. He also mentioned progress with the court-supervised process and the Rite Aid 2.0 Plan.
Press Release: Rite Aid Receives Court Approval for Sale of Elixir Solutions Business to MedImpactRite Aid was accused of recklessly implementing facial surveillance, leading to customer embarrassment and privacy threats. However, it rejected these allegations, claiming it was tied only to a terminated pilot project.
CNBC’s Jim Cramer outlined the ways that Federal Trade Commission chair Lina Khan has attempted to stop mergers and acquisitions from going through, hurting stock portfolios in the process.
“Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday. “Yep, Khan’s been a one-woman wrecking crew for your stoc...
“Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday. “Yep, Khan’s been a one-woman wrecking crew for your stoc...
7
Concerns rise as Rite Aid Corp's bankruptcy case may be harming low-ranking creditors by proceeding too quickly. Rite Aid stepping in with financing amid MedImpact's financial struggles in acquiring Rite Aid's pharmacy benefits manager could strain its resources.
Possible damage to corporate reputation and consumer trust in health product quality. Stricter rules and superior quality inspections might be needed, influencing operations and related expenses.
Read more